Top Research Institutions Reveal All

The three top-earning US medical schools, which together garnered nearly $1 billion (US) from the National Institutes of Health in 2001, employ strategies that lesser known institutions can also use, according to administrators. The medical faculties at Johns Hopkins University, the University of Pennsylvania, and the University of California, San Francisco, acquired nearly $982 million in NIH grants, more than 11% of the $8.67 billion awarded to 122 US medical schools in fiscal year 2001. Johns

Written byTed Agres
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Last month, the agency released its medical school rankings by total 2001 award amounts. The ability to raise federal funding helps schools dominate in the competition for talent, and each of the country's top 10 received more than $200 million in NIH grants. The top 30 medical schools received more than $100 million each. "Medical schools are major partners for the NIH in accomplishing our mission," says Wendy Baldwin, deputy NIH director for extramural research. "They are responsible for such a broad range of research and are especially critical when it comes time to translate basic research into clinical application. It is that translation that is the ultimate goal."

While many of the top earners obviously benefit from ample endowments and from reputations that attract ambitious faculty members, university deans say they have employed strategies that could prove beneficial to smaller institutions. "In the biomedical arena, Johns Hopkins has a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies